1Ware CF. Targeting the LIGHT-HVEM Pathway[J]. Adv Exp Med Biol, 2009, 647: 146-155.
2Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria[J]. Ann Neurol, 2011, 69(2): 292-302.
3Phillips TA, Ni J, Hunt JS. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are expressed in human placentae, cytotrophoblasts, placental macrophages and placental lines[J]. Placenta, 2001, 22(8-9): 663-672.
4Wang Y, Zhu M, Yu P, et al. Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition [J]. J Immunol, 2010, 184(3): 1589-1595.
5Liu GZ, Fang LB, Hjelmstrom P, et al. Enhanced plasma levels of LIGHT in patients with acute atherothrombotic stroke [J]. Acta Neurol Scand, 2008, 118(4): 256-259.
6Ogawa T, Homma T, Igawa Y, et al. CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis [J]. J Urol, 2010, 183 (3): 1206-1212.
